SAT046 Canagliflozin Leads To Less Weight Gain, Confers Changes In The Gut Microbiota And Extends Life Span In Male C57BL6 Mice

Disclosure: E.E. Habeos: None. F. Filippopoulou: None. M. Kanakis: None. G.I. Habeos: None. N. Belmokhtar: None. P. Stathopoulou: None. G. Tsiamis: None. S. Taraviras: None. G. Lagoumintzis: None. D.V. Chartoumpekis: None. Introduction: SGLT2 inhibitors (SGLT2i) are widely prescribed drugs for the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Habeos, Evagelia E, Filippopoulou, Fotini, Kanakis, Menelaos, Habeos, George I, Belmokhtar, Naima, Stathopoulou, Panagiota, Tsiamis, George, Taraviras, Stavros, Lagoumintzis, George, Chartoumpekis, Dionysios V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Diabetes And Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553535/
http://dx.doi.org/10.1210/jendso/bvad114.914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553535/
http://dx.doi.org/10.1210/jendso/bvad114.914

Ejemplares similares